Anagenics Ltd has released a press release.
Response to Appendix 4C Query
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Anagenics
- Cellmid Sets Another Sales Record in Q4 FY2019
- Cellmids Evolis Registered in European Union (EU)
- Minimum Holding Share Buy-Back
- Appendix 4D, Half Year Accounts and Strategy Update
- Significant New Findings Published on Midkine
Later from Anagenics
- CDY Signs Distribution Agreement for EVOLIS in South Korea
- Patent for Improved Midkine Antibody Allowed in Europe
- FY2019 Financial Results
- New Evolis Distribution & Supply Agreements - China & Europe
- New TV Shopping Agreement for Evolis
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics